Both Alzheimer s disease (AD) and type-2 diabetes mellitus (T2DM) are considered metal-enhanced aggregopathies, in which the anomalous interactions between copper(II) and the A(beta) and IAPP peptides, respectively, lead to protein misfolding, aggregation and oxidative stress. In this scenario, our research group proposed the use of 1-methylimidazole-containing N-acylhydrazones as metallophores, aiming to compete with the interaction of this metal ion with amyloidogenic proteins, intervening in the process of aggregation and restoring metal homeostasis. In the present work, two new compounds of this series were proposed, based on the structure of mescaline and nicotine: X1TMP and X1NIC. The first was evaluated in biophysical models of AD using the A(beta)1-40 peptide and its fragment A(beta)1-16 and was compared to its unsubstituted analogue X1Benz. X1NIC, on the other hand, was synthesized separately as its (E) and (Z) isomers, and they were in turn studied using the coordinating hIAPP18-22 fragment in the context of T2DM. X1TMP and X1Benz were both able to lessen the coppermediated production of ROS and prevent A(beta) aggregation in the presence and absence of this metal. The formation of ternary species with different stabilities was clearly demonstrated for the studied compounds in both AD and T2DM systems using different techniques. In the case of T2DM, however, only X1NIC- (E) seemed able to remove copper(II) from hIAPP18-22 at ligand excess conditions, which is consistent with its higher affinity for this ion. It is worth mentioning that all tridentate hydrazones [X1TMP, X1Benz and X1NIC-(E)] presented similar, moderate, apparent affinity constant values, while X1NIC-(Z) had a weaker interaction with copper since it performs as a bidentate ligand. In general, these new compounds demonstrated promising metallophoric activity and proved ability to interfere with the anomalous copper-peptide interactions. It is possible that the ternary species are enough to partially passivate the metal, avoiding deleterious redox cycling effects.